Regional distribution of HLA frequencies in the USA: implications for TCR-based therapies
Understanding regional distribution of HLA frequencies is crucial for optimizing enrollment in HLA-restricted clinical trials and to promote trial diversity per the Food and Drug Administration’s 2020 mandate. Using US HLA frequency data and census demographics we developed a method to create high-r...
Saved in:
| Main Authors: | Dirk Nagorsen, Christian Roy, Tomasz Sewastianik, Ileana Saenz, Gregory J Opiteck, Sean Stagg, Martin Maiers |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e011441.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
by: Xin Liu, et al.
Published: (2022-03-01) -
Modifications to rhesus macaque TCR constant regions improve TCR cell surface expression.
by: Lori V Coren, et al.
Published: (2025-01-01) -
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
by: Franziska Füchsl, et al.
Published: (2024-12-01) -
Editorial: A new perspective in immune polymorphism (the HLA, KIR, and LILR genes)
by: Seik-Soon Khor, et al.
Published: (2025-06-01) -
Human TCR repertoire in cancer
by: Lin Chen, et al.
Published: (2024-09-01)